Notice of AGM

Summary by AI BETAClose X

CRISM Therapeutics Corporation has announced that its Annual General Meeting will be held on Tuesday, October 27, 2026, at 11:00 am. The company, focused on localized chemotherapy drug delivery, has also commenced recruitment for its Phase 2 clinical trial of irinotecan-ChemoSeed for glioblastoma patients, a significant step in its development pipeline.

Disclaimer*

UK 100

Latest directors dealings